|
SOFRADIM PRODUCTION SAS MESH SOFRADIM - PARIETEX¿ COMPOSITE MESH MESH, SURGICAL, POLYMERIC
|
Back to Search Results |
|
| Model Number PCO9 |
| Device Problems
Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
|
| Patient Problems
Abscess (1690); Adhesion(s) (1695); Bacterial Infection (1735); Purulent Discharge (1812); Emotional Changes (1831); Fistula (1862); Unspecified Infection (1930); Inflammation (1932); Ischemia (1942); Internal Organ Perforation (1987); Pain (1994); Staphylococcus Aureus (2058); Hernia (2240); Injury (2348); Obstruction/Occlusion (2422); Ascites (2596); No Code Available (3191); Nodule (4551); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
|
Event Type
Injury
|
|
Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event Description
|
|
The patient's attorney alleged a deficiency against the device resulting in an unspecified adverse outcome.
Product was used for therapeutic treatment.
The patient underwent a right recurrent incisional hernia repair with mesh and panniculectomy.
The patient had revision/removal occurred on (b)(6) 2014 which was 6 years, 8 months later.
The patient experienced recurrence, chronic severe pain, extensive adhesions, a perforated viscus, an abdominal wall abscess, and infected ventral hernia mesh.
|
| |
|
Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event Description
|
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a right recurrent incisional hernia repair.
It was reported that after the implant, the patient experienced defective mesh, recurrence, chronic severe pain, fistula, extensive adhesions, a perforated viscus, an abdominal wall abscess, obstruction, pneumatosis, ischemic jejunal, ascites, sinus tract, fluid collection, staphylococcus aureus, inflammation, phlegmon, purulent material, mass in abdomen, air in the abdomen, infected ventral hernia mesh, mental pain, disability, impairment, and loss of enjoyment of life.
Post-operative patient treatment included revision surgery, lysis of adhesions, repair of enterotomy, icu stay, and excision of mesh.
|
| |
|
Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event Description
|
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a right recurrent incisional hernia repair.
It was reported that after the implant, the patient experienced recurrence, chronic severe pain, fistula,extensive adhesions, a perforated viscus, an abdominal wall abscess, obstruction, pneumatosis, ischemic jejunal, ascites, sinus tract, fluid collection, staphylococcus aureus, inflammation, phlegmon, purulent material, mass in abdomen, and infected ventral hernia mesh.
Post-operative patient treatment included revision surgery, lysis of adhesions, repair of enterotomy, icu stay, and excision of mesh.
|
| |
|
Manufacturer Narrative
|
|
This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Manufacturer Narrative
|
|
This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.
This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.
Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.
This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.
In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.
These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.
Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.
This statement should be included with any information or report disclosed to the public under the freedom of information act.
Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.
A good faith effort will be made to obtain the applicable information relevant to the report.
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event Description
|
|
The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a right recurrent incisional hernia repair.
It was reported that after the implant, the patient experienced recurrence, chronic severe pain, fistula,extensive adhesions, a perforated viscus, an abdominal wall abscess, and infected ventral hernia mesh.
Post-operative patient treatment included revision surgery and excision of mesh.
|
| |
|
Search Alerts/Recalls
|
|
|
